Literature DB >> 25145509

Familial hypercholesterolemia--screening to facilitate early prevention.

Klaus G Parhofer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25145509      PMCID： PMC4148711          DOI： 10.3238/arztebl.2014.0523

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  9 in total

1.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

Review 2.  ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Authors:  Alberico L Catapano; Zeljko Reiner; Guy De Backer; Ian Graham; Marja-Riitta Taskinen; Olov Wiklund; Stefan Agewall; Eduardo Alegria; M John Chapman; Paul Durrington; Serap Erdine; Julian Halcox; Richard Hobbs; John Kjekshus; Pasquale Perrone Filardi; Gabriele Riccardi; Robert F Storey; David Wood
Journal:  Atherosclerosis       Date:  2011-07       Impact factor: 5.162

3.  Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy.

Authors:  Frederick J Raal; Gillian J Pilcher; Vanessa R Panz; Hendrick E van Deventer; Brigitte C Brice; Dirk J Blom; A David Marais
Journal:  Circulation       Date:  2011-10-10       Impact factor: 29.690

4.  Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population.

Authors:  Marina A W Umans-Eckenhausen; Eric J G Sijbrands; John J P Kastelein; Joep C Defesche
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

Review 5.  Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.

Authors:  Gerald F Watts; Samuel Gidding; Anthony S Wierzbicki; Peter P Toth; Rodrigo Alonso; W Virgil Brown; Eric Bruckert; Joep Defesche; Khoo Kah Lin; Michael Livingston; Pedro Mata; Klaus G Parhofer; Frederick J Raal; Raul D Santos; Eric J G Sijbrands; William G Simpson; David R Sullivan; Andrey V Susekov; Brian Tomlinson; Albert Wiegman; Shizuya Yamashita; John J P Kastelein
Journal:  Int J Cardiol       Date:  2013-11-20       Impact factor: 4.164

6.  Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial.

Authors:  Frederick Raal; Rob Scott; Ransi Somaratne; Ian Bridges; Gang Li; Scott M Wasserman; Evan A Stein
Journal:  Circulation       Date:  2012-11-05       Impact factor: 29.690

7.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Authors:  C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins
Journal:  Lancet       Date:  2010-11-08       Impact factor: 79.321

8.  Effectiveness of two statin prescribing strategies with respect to adherence and cardiovascular outcomes: observational study.

Authors:  L Wei; T M MacDonald; A D Watson; M J Murphy
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-04       Impact factor: 2.890

9.  Efficacy of statins in familial hypercholesterolaemia: a long term cohort study.

Authors:  Jorie Versmissen; Daniëlla M Oosterveer; Mojgan Yazdanpanah; Joep C Defesche; Dick C G Basart; Anho H Liem; Jan Heeringa; Jacqueline C Witteman; Peter J Lansberg; John J P Kastelein; Eric J G Sijbrands
Journal:  BMJ       Date:  2008-11-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.